Virander S Chauhan Selected Research

Virander S Chauhan Research Topics

Disease

49	Malaria 12/2023 - 04/2002
15	Infections 12/2023 - 05/2005
4	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2023 - 08/2006
4	Vivax Malaria 01/2023 - 09/2006
3	Neoplasms (Cancer) 01/2018 - 01/2012
3	HIV Infections (HIV Infection) 03/2015 - 02/2012
3	Decompression Sickness (Bends) 12/2011 - 08/2007
3	Rupture 05/2008 - 06/2002
2	Parasitemia 05/2022 - 08/2006
1	Hepatitis B 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 04/2014
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 04/2014
1	Melanoma (Melanoma, Malignant) 01/2012
1	Parasitic Diseases (Parasitic Disease) 05/2008
1	AIDS-Related Complex (ARC) 04/2007
1	Coinfection 08/2006
1	Acquired Immunodeficiency Syndrome (AIDS) 08/2006

Drug/Important Bio-Agent (IBA)

21	VaccinesIBA 01/2023 - 03/2004
16	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2002
14	AntigensIBA 01/2023 - 04/2002
11	AntibodiesIBA 01/2023 - 09/2009
9	Immunoglobulin G (IgG)IBA 01/2023 - 09/2009
9	Merozoite Surface Protein 1 (MSA1)IBA 03/2015 - 03/2004
8	Peptides (Polypeptides)IBA 04/2014 - 04/2002
6	Antimalarials (Antimalarial Agents)IBA 03/2015 - 09/2003
6	Cysteine Proteases (Cysteine Protease)IBA 06/2008 - 09/2002
5	Peptide Hydrolases (Proteases)FDA Link 10/2013 - 06/2002
4	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 12/2023 - 01/2018
4	falcipain 2IBA 06/2008 - 04/2004
3	DipeptidesIBA 01/2018 - 01/2012
3	Recombinant ProteinsIBA 01/2015 - 05/2005
2	Immunoglobulin M (IgM)IBA 01/2018 - 01/2017
2	phenyldehydroalanineIBA 12/2013 - 01/2012
2	Surface Antigens (Surface Antigen)IBA 06/2013 - 04/2011
2	Chondroitin Sulfates (Chondroitin Sulfate)IBA 06/2013 - 04/2011
2	Histidine (L-Histidine)FDA Link 05/2010 - 12/2006
2	EnzymesIBA 09/2009 - 03/2007
2	hemozoinIBA 01/2005 - 09/2003
2	Heme (Haem)IBA 01/2005 - 09/2003
2	LipidsIBA 09/2003 - 05/2003
1	Carrier Proteins (Binding Protein)IBA 12/2023
1	TOR Serine-Threonine KinasesIBA 01/2018
1	LigandsIBA 01/2017
1	Antimicrobial PeptidesIBA 04/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2014
1	Folic Acid (Vitamin M)FDA LinkGeneric 12/2013
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2013
1	SubtilisinIBA 10/2013
1	P 11 (P-11)IBA 02/2012
1	insulin receptor-related receptor (IRR)IBA 02/2012
1	Amino Acids FDA Link 01/2012
1	Plasmodium falciparum serine repeat antigen 5IBA 01/2012
1	PeptidomimeticsIBA 01/2012
1	CurcuminIBA 01/2012
1	Membrane Proteins (Integral Membrane Proteins)IBA 02/2011
1	L-SelectinIBA 02/2011
1	LectinsIBA 02/2011
1	T-box transcription factor TBX21IBA 02/2011
1	Granzymes (Granzyme)IBA 02/2011
1	ATP-Dependent ProteasesIBA 08/2010
1	pyrimethamine drug combination fanasil (Fansidar)FDA Link 01/2010
1	ImmunosorbentsIBA 09/2009
1	HMGB1 Protein (HMG1)IBA 06/2008
1	Hemoglobins (Hemoglobin)IBA 05/2008
1	Interleukin-4 (Interleukin 4)IBA 03/2007
1	CytokinesIBA 03/2007
1	AzurinIBA 08/2006
1	Small Interfering RNA (siRNA)IBA 11/2005
1	Serine (L-Serine)FDA Link 11/2005
1	Protease Inhibitors (Protease Inhibitor)IBA 11/2005
1	falcipainIBA 11/2005
1	beta Karyopherins (Importin-beta)IBA 05/2005
1	type I signal peptidase (signal peptidase)IBA 01/2005
1	Chloroquine (Aralen)FDA LinkGeneric 09/2003
1	histidine-rich proteinsIBA 09/2003
1	artemisinin (artemisinine)IBA 09/2003
1	Biotin (Vitamin H)FDA Link 05/2003
1	StreptavidinIBA 05/2003
1	Human Serum Albumin FDA LinkGeneric 05/2003
1	Double-Stranded RNA (RNA, Double Stranded)IBA 09/2002
1	NucleotidesIBA 09/2002
1	Plasmodium falciparum erythrocyte membrane protein 1IBA 04/2002

Therapy/Procedure

2	Therapeutics 12/2013 - 01/2012
1	Intravenous Injections 01/2018
1	Phytotherapy (Herbal Therapy) 01/2012